2009
DOI: 10.1016/j.lungcan.2009.01.008
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic value of the apoptotic index analysed jointly with selected cell cycle regulators and proliferation markers in non-small cell lung cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
13
0

Year Published

2009
2009
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 19 publications
(16 citation statements)
references
References 36 publications
(58 reference statements)
3
13
0
Order By: Relevance
“…This method supports the identification of ovarian cells with characteristic symptoms of apoptosis, including those in early stages of suicide when morphological changes are not clearly pronounced (Jiang et al 2011). In most studies (including the present work), the presence of apoptotic cells is determined with the use of the AI, which indicates the percentage of apoptotic cells in 1000 cells (Dworakowska 2005). In our experiment, the AI median for the entire group of 30 bitches reached 13.…”
Section: Discussionsupporting
confidence: 72%
See 1 more Smart Citation
“…This method supports the identification of ovarian cells with characteristic symptoms of apoptosis, including those in early stages of suicide when morphological changes are not clearly pronounced (Jiang et al 2011). In most studies (including the present work), the presence of apoptotic cells is determined with the use of the AI, which indicates the percentage of apoptotic cells in 1000 cells (Dworakowska 2005). In our experiment, the AI median for the entire group of 30 bitches reached 13.…”
Section: Discussionsupporting
confidence: 72%
“…Multiple fields must be evaluated when positively stained nuclei are not evenly distributed. PCNA expression varies in different sections of the same ovarian tissue; therefore, the final percentage of stained nuclei is strictly determined by the size of the analysed specimen and the number of viewed fields (Dworakowska 2005). The proliferative activity of the ovarian follicles studied was less pronounced in both experimental groups, as demonstrated by the overall PI median of 25.49.…”
Section: Discussionmentioning
confidence: 92%
“…However, we found that lncRNA DLEU2 promoted the proliferation and invasion of NSCLC cells, but inhibition of lncRNA DLEU2 reversed these effects. PCNA and MMP‐2, tumour proliferation and invasion related markers, act as the poor prognostic factors in NSCLC . We found that lncRNA DLEU2 induced their expression levels and acted as an oncogene in NSCLC.…”
Section: Discussionmentioning
confidence: 78%
“…In another study by Langendijk et al (Langendijk et al 2000), high AI was associated with worse local control, more distant metastases and a significantly worse overall survival in patients with inoperable NSCLC treated with high-dose radiotherapy. Furthermore, Dworakowska et al (Dworakowska et al 2009) found that NSCLC patients with very high AI values combined with very high PCNA (proliferating cell nuclear antigen) labeling index had a particularly poor prognosis and concluded that joint analysis of several apoptosis, proliferation and cell cycle regulation biomarkers may provide more useful prognostic information as compared to AI alone. On the other hand, other researchers failed to reveal any association between AI and survival in patients with NSCLC (Gorgoulis et al 2000).…”
Section: Reviewmentioning
confidence: 99%
“…The aim of this study was to perform a review of the MEDLINE literature in an attempt to determine the exact clinical value of tumor necrosis and apoptotic index (AI) as prognostic biomarkers in NSCLC. We retrieved 28 papers, investigating the prognostic significance of necrosis and/or apoptosis in patients with primary NSCLC (Tables 1 and 2) (Lipford et al 1984; Elson et al 1988; Lee et al 1989; Roeslin et al 1991; Roberts et al 1992; Shahab et al 1992; Tormanen et al 1995; Kessler et al 1996; Goldstein et al 1999; Swinson et al 2002; Poleri et al 2003; Khan et al 2004; Rena et al 2007; Inoue et al 2008; Cho et al 2008; Sardari Nia et al 2010; Kiliçgün et al 2010; Park et al 2011; Pataer et al 2012; Tantraworasin et al 2013; Komaki et al 1996; Tanaka et al 1999; Matturi et al 1999; Langendijk et al 2000; Gorgoulis et al 2000; Hwang et al 2001; Puglisi et al 2002; Dworakowska et al 2009). Studies on apoptosis-related genes were excluded.…”
Section: Introductionmentioning
confidence: 99%